Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria
Patients with CSU experience substantial burden due to delayed diagnosis, insufficient symptom control (despite treatment) as well as mental and emotional well-being and social impact, particularly when uncontrolled. Early diagnosis and patient-centered approaches to symptom management and disease control should be prioritized to minimize the negative impact of CSU on patients' life.
Authors
- Pallavi Prakash Saraswat (ORCID: https://orcid.org/0000-0002-4374-9543)
- Tonya Winders (ORCID: https://orcid.org/0000-0001-7689-6438)
- Jessica McCarthy (ORCID: https://orcid.org/0000-0002-5771-2274)
- Karsten Weller (ORCID: https://orcid.org/0000-0003-4437-0313)
- Tara C. Raftery
- Jonathan A. Bernstein (ORCID: https://orcid.org/0000-0001-5369-346X)
- M.M. Balp
- C Constantinescu
Institutions
- Novartis (Switzerland) (CH)
- Asthma and Allergy Foundation of America (US)
- Humboldt-Universität zu Berlin (DE)
- Novartis (India) (IN)
- Bernstein Clinical Research Center (US)
- Novartis (United States) (US)
- Novartis (Ireland) (IE)
- University of Cincinnati (US)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1007/s13555-025-01348-8
- Citations
- 16
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 26.69
Funders
- Novartis